Blood type gene locus has no influence on ACE association with Alzheimer's disease

Alzheimer's Research UK (ARUK) Consortium

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The ABO blood group locus was recently found to contribute independently and via interactions with angiotensin-converting enzyme (. ACE) gene variation to plasma levels of ACE. Variation in ACE has previously been not only implicated as individually conferring susceptibility for Alzheimer's disease (AD) but also proposed to confer risk via interactions with other as yet unknown genes. More recently, larger studies have not supported ACE as a risk factor for AD, whereas the role of ACE pathway in AD has come under increased levels of scrutiny with respect to various aspects of AD pathology and possible therapies. We explored the potential combined involvement of ABO and ACE variations in the genetic susceptibility of 2067 AD cases compared with 1376 nondemented elderly. Including the effects of ABO haplotype did not provide any evidence for the genetic association of ACE with AD.

Original languageEnglish (US)
Pages (from-to)1767.e1-1767.e2
JournalNeurobiology of Aging
Volume36
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Alzheimer Disease
Genes
Peptidyl-Dipeptidase A
Genetic Predisposition to Disease
Blood Group Antigens
Haplotypes
Pathology
Therapeutics

Keywords

  • ABO blood group
  • Alzheimer's disease
  • Angiotensin-converting enzyme
  • Genome-wide association study

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Blood type gene locus has no influence on ACE association with Alzheimer's disease. / Alzheimer's Research UK (ARUK) Consortium.

In: Neurobiology of Aging, Vol. 36, No. 4, 01.04.2015, p. 1767.e1-1767.e2.

Research output: Contribution to journalArticle

Alzheimer's Research UK (ARUK) Consortium. / Blood type gene locus has no influence on ACE association with Alzheimer's disease. In: Neurobiology of Aging. 2015 ; Vol. 36, No. 4. pp. 1767.e1-1767.e2.
@article{cd7d128d4acb40b9a57baf5908ab505f,
title = "Blood type gene locus has no influence on ACE association with Alzheimer's disease",
abstract = "The ABO blood group locus was recently found to contribute independently and via interactions with angiotensin-converting enzyme (. ACE) gene variation to plasma levels of ACE. Variation in ACE has previously been not only implicated as individually conferring susceptibility for Alzheimer's disease (AD) but also proposed to confer risk via interactions with other as yet unknown genes. More recently, larger studies have not supported ACE as a risk factor for AD, whereas the role of ACE pathway in AD has come under increased levels of scrutiny with respect to various aspects of AD pathology and possible therapies. We explored the potential combined involvement of ABO and ACE variations in the genetic susceptibility of 2067 AD cases compared with 1376 nondemented elderly. Including the effects of ABO haplotype did not provide any evidence for the genetic association of ACE with AD.",
keywords = "ABO blood group, Alzheimer's disease, Angiotensin-converting enzyme, Genome-wide association study",
author = "{Alzheimer's Research UK (ARUK) Consortium} and Anne Braae and Christopher Medway and Carrasquillo, {Minerva M} and Younkin, {Steven G} and Kehoe, {Patrick G.} and Kevin Morgan and David Craig and Janet Johnston and Bernadette McGuinness and Stephen Todd and Reinhard Heun and Heike K{\"o}lsch and Vardy, {Emma R L C} and Hooper, {Nigel M.} and Mann, {David M.} and Stuart Pickering-Brown and Imelda Barber and James Lowe and Smith, {A. David} and Gordon Wilcock and Donald Warden and Clive Holmes",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.neurobiolaging.2015.01.013",
language = "English (US)",
volume = "36",
pages = "1767.e1--1767.e2",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Blood type gene locus has no influence on ACE association with Alzheimer's disease

AU - Alzheimer's Research UK (ARUK) Consortium

AU - Braae, Anne

AU - Medway, Christopher

AU - Carrasquillo, Minerva M

AU - Younkin, Steven G

AU - Kehoe, Patrick G.

AU - Morgan, Kevin

AU - Craig, David

AU - Johnston, Janet

AU - McGuinness, Bernadette

AU - Todd, Stephen

AU - Heun, Reinhard

AU - Kölsch, Heike

AU - Vardy, Emma R L C

AU - Hooper, Nigel M.

AU - Mann, David M.

AU - Pickering-Brown, Stuart

AU - Barber, Imelda

AU - Lowe, James

AU - Smith, A. David

AU - Wilcock, Gordon

AU - Warden, Donald

AU - Holmes, Clive

PY - 2015/4/1

Y1 - 2015/4/1

N2 - The ABO blood group locus was recently found to contribute independently and via interactions with angiotensin-converting enzyme (. ACE) gene variation to plasma levels of ACE. Variation in ACE has previously been not only implicated as individually conferring susceptibility for Alzheimer's disease (AD) but also proposed to confer risk via interactions with other as yet unknown genes. More recently, larger studies have not supported ACE as a risk factor for AD, whereas the role of ACE pathway in AD has come under increased levels of scrutiny with respect to various aspects of AD pathology and possible therapies. We explored the potential combined involvement of ABO and ACE variations in the genetic susceptibility of 2067 AD cases compared with 1376 nondemented elderly. Including the effects of ABO haplotype did not provide any evidence for the genetic association of ACE with AD.

AB - The ABO blood group locus was recently found to contribute independently and via interactions with angiotensin-converting enzyme (. ACE) gene variation to plasma levels of ACE. Variation in ACE has previously been not only implicated as individually conferring susceptibility for Alzheimer's disease (AD) but also proposed to confer risk via interactions with other as yet unknown genes. More recently, larger studies have not supported ACE as a risk factor for AD, whereas the role of ACE pathway in AD has come under increased levels of scrutiny with respect to various aspects of AD pathology and possible therapies. We explored the potential combined involvement of ABO and ACE variations in the genetic susceptibility of 2067 AD cases compared with 1376 nondemented elderly. Including the effects of ABO haplotype did not provide any evidence for the genetic association of ACE with AD.

KW - ABO blood group

KW - Alzheimer's disease

KW - Angiotensin-converting enzyme

KW - Genome-wide association study

UR - http://www.scopus.com/inward/record.url?scp=84925304501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925304501&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2015.01.013

DO - 10.1016/j.neurobiolaging.2015.01.013

M3 - Article

C2 - 25681990

AN - SCOPUS:84925304501

VL - 36

SP - 1767.e1-1767.e2

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 4

ER -